Literature DB >> 30175625

What are the economic barriers of antibiotic R&D and how can we overcome them?

Mathew Renwick1, Elias Mossialos1.   

Abstract

Entities:  

Keywords:  Antibiotics; antimicrobial resistance; drug development; drug discovery; health policy; incentives

Mesh：

Substances：

Year:  2018        PMID： 30175625     DOI： 10.1080/17460441.2018.1515908

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  13 in total

Review 1.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 2.  Renewed interests in the discovery of bioactive actinomycete metabolites driven by emerging technologies.

Authors:  Jenifer Ossai; Behnam Khatabi; S Eric Nybo; Madan K Kharel
Journal:  J Appl Microbiol       Date:  2021-07-29       Impact factor: 3.772

3.  Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria.

Authors:  Majed M Masadeh; Karem H Alzoubi; Majd M Masadeh; Zainah O Aburashed
Journal:  Clin Pharmacol       Date:  2021-05-11

4.  Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to P. aeruginosa PhzS.

Authors:  Thamires Quadros Froes; Bianca Trindade Chaves; Marina Sena Mendes; Rafael Matos Ximenes; Ivanildo Mangueira da Silva; Priscila Brandão Gomes da Silva; Julianna Ferreira Cavalcanti de Albuquerque; Marcelo Santos Castilho
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  Reflections on the COVID-19 pandemic in the USA: Will we be better prepared next time?

Authors:  Gonzalo Bearman; Rachel Pryor; Rebecca Vokes; Kaila Cooper; Michelle Doll; Emily J Godbout; Michael P Stevens
Journal:  Int J Infect Dis       Date:  2020-05-20       Impact factor: 3.623

6.  Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities.

Authors:  Kenneth Timmis; James Kenneth Timmis; Harald Brüssow; Luis Ángel Fernández
Journal:  Microb Biotechnol       Date:  2019-01       Impact factor: 5.813

7.  Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.

Authors:  Natalia V Kirienko; Laurence Rahme; You-Hee Cho
Journal:  Front Cell Infect Microbiol       Date:  2019-10-11       Impact factor: 5.293

Review 8.  Towards better diagnostic tools for liver injury in low-income and middle-income countries.

Authors:  Saundria Moed; Muhammad H Zaman
Journal:  BMJ Glob Health       Date:  2019-07-18

9.  The antimicrobial potential of cannabidiol.

Authors:  Mark A T Blaskovich; Angela M Kavanagh; Alysha G Elliott; Bing Zhang; Soumya Ramu; Maite Amado; Gabrielle J Lowe; Alexandra O Hinton; Do Minh Thu Pham; Johannes Zuegg; Neil Beare; Diana Quach; Marc D Sharp; Joe Pogliano; Ashleigh P Rogers; Dena Lyras; Lendl Tan; Nicholas P West; David W Crawford; Marnie L Peterson; Matthew Callahan; Michael Thurn
Journal:  Commun Biol       Date:  2021-01-19

10.  Bioprospecting Staphylococcus Phages with Therapeutic and Bio-Control Potential.

Authors:  Joseph M Ochieng' Oduor; Ermir Kadija; Atunga Nyachieo; Marianne W Mureithi; Mikael Skurnik
Journal:  Viruses       Date:  2020-01-23       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.